With this grant, CND will support the largest study of its kind to enhance the precision and clinical utility of its Syn-One Test, which is being adopted by neurologists to improve the diagnosis of neurodegenerative disorders, notably Parkinson’s.
The device blends enhanced slow-flow rates with precision dispensing for increased application flexibility across a wide volume range.Read More
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.Read More
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.Read More
The concept of prevention is expanding, notes principal investigator Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at The Methodist Hospital.Read More
The study found success in utilizing a new method of delivery of a potent biotechnology anti-inflammatory therapeutic. Pictured is a patient dialing a phone an hour after treatment, something he’d previously been unable to do after his stroke.Read More
New research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.Read More
A new statistical model could be used to predict an individuals lifetime risk of stroke, finds a study from the Childrens Hospital Informatics Program (CHIP).Read More